The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorOvation Fertility

About this trial

The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.

Eligibility criteria

Qualifiers

Fresh MII oocytes

ICSI cycles with patient's or donor's sperm

Patient's or donor's oocytes

Full IVF cycle information available (including total number of oocytes retrieved, total MII oocytes, fertilization, embryo and blastocyst development, as well as ploidy status or implantation results, and 6-7 week ultrasound, if applicable)

Disqualifiers

Severe male factor infertility (<1 million motile), including surgically retrieved sperm.

ICSI cycles inseminating in vitro matured (IVM) oocytes

Rescue ICSI oocytes (oocytes failed standard IVF and are re-inseminated by ICSI)

Low quality images - Poor quality images on day of upload or before unblinding

Trial design

Treatments tested in this trial

  • Magenta AI image analysis tool

Treatment groups

450 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ovation Fertility

Lead sponsor

Future Fertility Inc.

Collaborator